第6届欧洲肺癌大会(ELCC 2016)将在瑞士日内瓦的Palexpo展览中心举行,会议召开时间为2016年4月13日至4月16日。欧洲肺癌大会的目标是推动科学进步、传播胸部肿瘤知识和改进临床实践。本次会议的主题为:IASLC新分期系统、WHO肺癌新病理分类、免疫治疗、不同分子分型非小细胞肺癌的治疗新进展、肺癌筛查、立体定向放射治疗和微创局部治疗。
Room B
|
Room A
|
13:30 - 14:15
开幕式
Heine H. Hansen奖颁奖典礼
|
|
14:30 - 16:00
小细胞肺癌研究进展(SCLC: Advances and state of the art)
|
14:30 - 16:00
间皮瘤研究进展(Mesothelioma: An update)
|
16:30 - 18:00
靶向 T790M 突变(Targeting T790M )
中国专家报告
王洁教授: T790M突变血液检测的技术进步(Advancing technology on blood-based testing for detection of T790M)
|
16:30 - 18:00
寡转移性非小细胞肺癌的治疗(Oligometastatic NSCLC)
中国专家报告
陆舜教授:有驱动基因突变的寡转移性NSCLC指南与临床实践(Oligometastatic NSCLC with driver mutations: Guidelines and practical application)
吴一龙教授:寡转移性NSCLC手术(Surgery in oligometastatic disease)
|
4月14日
Room B
|
Room A
|
Room C
|
Room W
|
Room X
|
08:00 - 08:50
优化有致癌基因的非小细胞肺癌的TKI治疗(Optimizing the use of TKI in oncogene addicted NSCLC)
|
|
|
08:00 - 08:50
转移性非小细胞肺癌立体定向放射治疗(Stereotactic radiotherapy for metastatic NSCLC)
|
08:00 - 08:50
小细胞肺癌研究新发现(What is new in small cell lung cancer )
|
09:00 - 10:30
靶向ALK(Targeting ALK)
|
09:15 - 10:15
筛查对于非小细胞肺癌的作用?(Does screening have any role in NSCLC? )
|
09:00 - 10:30
预防吸烟与戒烟(Smoking prevention and cessation)
|
|
|
11:00 - 12:30
KRAS、PIK3CA、FRGF1/2靶点(The difficult targets: KRAS, PIK3CA and FRGF1/2)
|
11:00 - 12:30
非小细胞肺癌的分子特征:我们应该为我们的病人做什么?(Molecular characterisation of NSCLC: What should we really get for our patients?)
|
11:00 - 12:30
非小细胞肺癌放射治疗的 现状与研究前沿(Radiation Oncology NSCLC: Current developments and state-of-the-art)
|
11:00 - 12:30
内镜研究新领域(New frontiers in endoscopy)
|
11:00 - 12:30
亚肺叶切除的时机和技术(Sublobar resections: When and how)
|
14:10 - 14:40
目前和未来的癌症治疗策略之基础免疫疗法(Basic immunotherapy for current and future cancer treatment strategies)
|
|
|
|
|
14:45 - 16:15
EGFR突变非小细胞肺癌的新治疗策略(New strategies for EGFR addicted NSCLC)
|
14:45 -16:15
放射治疗剂量和剂量分割(Radiotherapeutic issues of dose and fractionation)
|
|
14:45 -16:00
靶向EGFR和ALK驱动基因(Targeting EGFR and ALK driver tumors)
|
|
16:45 - 18:15
IASLC 非小细胞肺癌新分期系统(The IASLC new staging system in NSCLC)
|
16:45 - 18:15
胸部肿瘤多学科治疗( Multidisciplinary management of thoracic malignancies)
|
|
16:45 - 18:00
化疗和放疗的预测模型(Predictive models for chemo- and radiotherapy)
|
|
4月15日
Room B
|
Room A
|
Room C
|
Room W
|
Room X
|
|
08:00 - 08:50
TKI与其他治疗方式联合治疗(Combining TKI with other strategies)
|
|
08:00 - 08:50
小细胞肺癌与非小细胞肺癌的PCI治疗(PCI in SCLC and NSCLC)
|
08:00 - 08:50
整合肺癌筛查与支持治疗(Integrating screening and supportive care in the lung cancer pathway)
|
09:00 - 10:30
肺癌免疫治疗(Immunotherapy)
|
09:15 - 10:15
胸膜间皮瘤可做何种手术?(Is any type of surgery worth doing in pleural mesothelioma?)
|
09:00 - 10:45
非小细胞肺癌靶向治疗与循环生物标志物(NSCLC targeted therapy and circulating biomarkers)
|
|
|
11:00 - 12:30
如何改善Ⅲ期非小细胞肺癌的综合治疗(How to improve stage III NSCLC multimodality treatment)
|
11:00 - 12:30
新的分子靶标
(New molecular targets of interest)
|
11:00 - 12:30
恶性胸腺瘤新进展(Thymic malignancy: An update)
|
|
|
14:10 - 14:40
肺癌铂类治疗历史[(History of) Platinum in lung cancer]
|
14:45 - 16:15
第8版TNM分期系统有哪些改变?(What has changed with the 8th TNM staging system?)
|
14:45 - 16:15
肺癌的治疗期间急症(Therapeutic emergencies in lung cancer)
|
14:45 - 15:45
生物标志物(Biomarkers)
|
|
4月16日
Room A
|
08:45 - 09:15
肺癌护理:最近和未来5年展望(Lung cancer care: The last and the next 5 years perspectives)
|
09:20 - 10:50
WHO 2015
|
11:20 - 12:50
微创局部治疗(Minimally invasive local approaches)
|